Pharmacy Department, Ramón y Cajal University Hospital (IRYCIS), Madrid, Spain.
Clinical Biostatistics Unit, Ramón y Cajal University Hospital (IRYCIS), Madrid, Spain.
Eur Geriatr Med. 2021 Jun;12(3):509-544. doi: 10.1007/s41999-021-00487-3. Epub 2021 May 7.
To identify the evidence that supports the effect of interventions made by hospital pharmacists, individually or in collaboration with a multidisciplinary team, in terms of healthcare outcomes, a more effective utilization of resources and lower costs in older polymedicated inpatients.
We searched the following databases: MEDLINE, EMBASE and the Cochrane Library. We also conducted a hand search by checking the references cited in the primary studies and studies included in reviews identified during the process of research. Four review authors working by pairs searched for studies, extracted data, and drew up the results tables.
Twenty-six studies were included in the review. In 13 of them pharmacists carried out their intervention exclusively while the patients were in hospital, whereas in 13 interventions were delivered during admission and after hospital discharge. Outcomes identified were mortality, length of stay, visits to the emergency department, readmissions and reported quality of life, among others. Pharmacist interventions were found to be beneficial in fifteen studies, specifically on hospital readmissions, visits to the emergency department and healthcare costs.
There is no hard evidence demonstrating the effectiveness of hospital pharmacist interventions in older polymedicated patients. Mortality does not show as a relevant outcome. Other health care outcomes, such as hospital readmissions, visits to the emergency department and healthcare costs, seem to be more relevant and amenable to change. Interventions that include pharmacists in multidisciplinary geriatric teams seem to be more promising that isolated pharmacist interventions. Interventions prolonged after hospital discharge seem to be more appropriate that interventions delivered only during hospital admission. Better-designed studies should be conducted in the future to provide further insight into the effect of hospital pharmacist interventions.
确定医院药师单独或与多学科团队合作进行干预的效果证据,这些干预措施在医疗保健结果、资源更有效利用和降低老年多药治疗住院患者成本方面的证据。
我们搜索了以下数据库:MEDLINE、EMBASE 和 Cochrane 图书馆。我们还通过检查主要研究和综述中包含的研究的参考文献进行了手工搜索。四名审查员成对搜索研究、提取数据和制定结果表。
综述纳入了 26 项研究。其中 13 项研究中,药师仅在患者住院期间进行干预,而在 13 项研究中,干预措施是在住院期间和出院后进行的。确定的结果包括死亡率、住院时间、急诊就诊、再入院和报告的生活质量等。有 15 项研究表明药师干预是有益的,特别是在医院再入院、急诊就诊和医疗保健成本方面。
没有确凿的证据表明医院药师干预对老年多药治疗患者有效。死亡率并不是一个相关的结果。其他医疗保健结果,如医院再入院、急诊就诊和医疗保健成本,似乎更相关,也更容易改变。包括药师在内的多学科老年团队的干预措施似乎比单独的药师干预更有希望。出院后延长的干预措施似乎比仅在住院期间进行的干预措施更合适。未来应进行更好设计的研究,以进一步了解医院药师干预的效果。